Overview. In Vitro Fertilization: a Success Story

Similar documents
Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification

IVF Health Risk 503,000 Hit in Google in 0.2 seconds

Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization

Articles Follow-up of children born after assisted reproductive technologies

Gestational Diabetes: An Update on Testing. Kimberlee A McKay, M.D. Avera Medical Group Ob/GYN

Report to the Director-General of Health on the Risks and Benefits Associated with Assisted Reproductive Technologies

IVF/ICSI twin pregnancies: risks and prevention

2/13/2018. Update on Gestational Diabetes. Disclosure. Objectives. I have no financial conflicts of interest.

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.

Article Obstetric and perinatal outcome of 1655 ICSI and 3974 IVF singleton and 1102 ICSI and 2901 IVF twin births: a comparative analysis

Gestational Diabetes. Gestational Diabetes:

Management of Pregestational and Gestational Diabetes Mellitus

Review of unexplained infertility and obstetric outcome: a 10 year review

Disclosures. Win Fertility UpToDate

Dr Manuela Toledo - Procedures in ART -

The Ever-Changing Approaches to Diabetes in Pregnancy

Fertility Preservation By Dr Mary Birdsall Chair, Fertility Associates

OUTCOMES OF INFANTS EXPOSED TO MULTIPLE ANTIDEPRESSANTS DURING PREGNANCY: RESULTS OF A COHORT STUDY

Committee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler

COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)

MFMU - Background. MFMU - Background MFMU GOALS

The first live birth after the transfer

The New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program

Increase your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0)

PRETREATMENT ASSESSMENT & MANAGEMENT (MODULE 1 B) March, 2018

Should every pregnant woman be screened for thyroid disease?

Comparative study of obstetric and neonatal outcomes of live births between poor- and good- quality embryo transfers

Gestational Diabetes. Benjamin Byers, D.O., FACOG Center for Maternal and Fetal Care Bryan Physician Network

Embryo Selection after IVF

Imprinting diseases and IVF. Øjvind Lidegaard Dept. Obstetrics & Gynaecology Herlev University Hospital Copenhagen, Denmark

Original Article Pregnancy Complications - Consequence of Polycystic Ovary Syndrome or Body Mass Index?

Vishwanath Pattan Endocrinology Wyoming Medical Center

Reproductive Technologies and the Risk of Birth Defects

Surveillance report Published: 9 January 2017 nice.org.uk

Gestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ)

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Labor & Delivery Management for Women Living with HIV. Pooja Mittal, DO Lisa Rahangdale, MD

Cite this article as: BMJ, doi: /bmj ae (published 7 August 2006)

Gestational Diabetes Mellitus Dr. Fawaz Amin Saad

The costs to the NHS of multiple births after IVF treatment in the UK

OOCYTE DONATION: AN OVERVIEW

Disclosures. Diagnosis and Management of Diabetes in Pregnancy. I have nothing to disclose. Type 1. Overview GDMA1

Pharmacologic Considerations in the Pregnant Patient (For the PCP)

CONTROVERSY: MULTIPLE BIRTHS: WHAT DO PATIENTS WANT?

Access from the University of Nottingham repository:

Pregnancy in women after infertility treatment

Patrick Duff, M.D. University of Florida

Screening and Diagnosis of Diabetes Mellitus in Taiwan

FACTORS ASSOCIATED WITH DIZYGOTIC TWINNING AFTER IVF TREATMENT WITH DOUBLE EMBRYO TRANSFER

Supplementary Online Content

Number of oocytes and live births in IVF

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018

Reproductive Technology, Genetic Testing, and Gene Therapy

Supplemental figure 1. Adjusted odds ratios for gestational diabetes, pre-eclampsia, premature birth and miscarriage for women with and without PCOS.

Understanding IVF Processes in Surrogacy

Registers of in-vitro fertilization and assisted conception

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014

Basic Doppler Assessment of Fetal Distress

How to advise the couple planning to conceive: Modifiable factors that may (or may not) impact fertility

Diabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016

Systematic review of the health risks to the mother, child and family associated with the use of intracytoplasmic sperm injection (ICSI)

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine

Infertility, infertility treatment and twinning: the Danish National Birth Cohort

Original Policy Date

Diagnosis of gestational diabetes mellitus: comparison between National Diabetes Data Group and Carpenter Coustan criteria

Problems in PCOS pregnancy

Bipolar disorder in pregnancy and childbirth: a systematic review of outcomes

2018 Standard of Medical Care Diabetes and Pregnancy

Oral glucose lowering agents in gestational diabetes. Yes: E. Sobngwi (Cameroon) No: A. Vambergue (France)

Pregnancy Outcomes After Assisted Human Reproduction

IS PCOS ASSOCIATED WITH A HIGHER PREGNANCY LOSS? NO BY DR SHEELA V.MANE

Opioid Use Disorder- Pregnancy Principles and Myths. Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center

Disclosure. Lyubov Mykhaylshyn IVF department Alternativa clinic Lviv, Ukraine

Medication Policy Manual. Topic: Makena, hydroxyprogesterone caproate Date of Origin: March 28, 2011

Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

The high risk neonate

IVF Treatment Plan & Consents

Prevention of Perinatal HIV Transmission

Overt and subclinical hypothyroidism among Bangladeshi pregnant women and its effect on fetomaternal outcome

Informed Consent for Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, Embryo Cryopreservation

European IVF Monitoring (EIM) Year: 2013

Original paper A.-S. MARYNS 1, I. DEHAENE 1, G. PAGE 2. Abstract

Pregnancy outcomes in Korean women with diabetes

METFORMIN A CONVENIENT ALTERNATIVE TO INSULIN FOR INDIAN WOMEN WITH DIABETES IN PREGNANCY

Complications of Pregnancy and Lifetime Risk to Health. Brian McCulloch MD Advocate Lutheran General Hospital September 26, 2015

ADVERSE PREGNANCY OUTCOMES IN GESTATIONAL DIABETES MELLITUS - STUDY IN AN APEX HOSPITAL

Infant and maternal health monitoring using a combined Nordic database on ART and safety

Current Trends in Diagnosis and Management of Gestational Diabetes

Pregnancy outcome in women with polycystic ovary syndrome

Reminder: NPIC/QAS CME/CEU Program

HYPOXIC ISCHEMIC ENCEPHALOPATHY AND THE OBSTETRICIAN

Labour Epidurals and Maternal Pyrexia

4/15/2019. Dickson, et al Obstet Gynecol Marijuana Use and Pregnancy. Conner, et al AJOG Conner, et al Obstet and Gynecol 2016

Recent Developments in Infertility Treatment

Dr Devashana Gupta. Dr Karen Buckingham. Obstetrician and Gynaecologist Repromed. Repromed Auckland

The significance of genomic imprinting in assisted reproduction

RISK OF EARLY & LATE OBSTETRIC COMPLICATIONS IN WOMEN WITH IVF- CONCEIVED PREGNANCIES AND POLYCYSTIC OVARY SYNDROME (PCOS)

Age-specific success rate for women undertaking their first assisted reproduction technology treatment using their own oocytes in Australia,

Transcription:

Does IVF cause adverse perinatal outcomes? Paolo Rinaudo *, MD PhD Rebecca A. Jackson %, MD Departments of Ob/Gyn & *Center for Reproductive Sciences & % Epi/Biostats University of California, San Francisco Overview 1. Background (success and risks of in vitro fertilization) 2. Meta-analysis results ( Dr. Jackson) 3. Potential mechanisms & Barker hypothesis 1. In Vitro Fertilization: a Success Story 2 million children conceived through IVF one in 80-100 babies born in the world is conceived by IVF estimated annual number of IVF cycles worldwide: ~ 500,000 Pregnancy rate/cycle 35% SART data 2002 1

ART Pregnancy Complications Early pregnancy: Ectopic (3-5%), heterotopic (0.5-1%) Ovarian hyperstimulation Multiple gestation (20-30%) Real problem: multiple gestations Twins vs. 10 x higher rate of PTD 7X higher rate of PTD <32 wks 2X higher rate of PNM Increased pre-eclampsia, GDM Higher rates of malformations Longer hospital stay The 2002 Revolution Stromberg Sweden, Sweden, Lancet 359:461, 2/2002 incidence of neurological sequalae: OR 1.7 Hansen Australia, NEJM 346:725, 3/2002 incidence of major birth defects: OR= 2 Hansen Schieve CDC CDC, NEJM 346:731, 3/2002 incidence of low birth weight in singleton: RR 2.6 Bonduelle, Belgium Hu Reprod 16:671,2002 ~ incidence of major birth defects comparing ICSI vs. IVF: 3.4% vs. 3.8% Problems with the literature No RCT s (not ethical) Most studies are not controlled for age and parity Many studies include various types of ART in one group (IVF, ICSI, IUI, ovarian stimulation). Many studies are small 2

2. The question is.. Do IVF pregnancies have worse perinatal outcomes than naturally conceived pregnancies even when controlled for age, parity and number of gestations? 3 meta-analyses Studies included slightly different as a result of differing inclusion criteria 1. Jackson: only studies matched for age and parity 2. Helmerhorst: matched and unmatched 3. McDonald: matched for age Analyses slightly different All 3 came to same conclusions with similar odds ratios ; Helmerhorst, BMJ, 2004, McDonald, J Ob- Gyn Canada; 2005 Inclusion Criteria Singleton gestations resulting from IVF and/or GIFT. Comparison group=spontaneous conception Controlled for at least age and parity Primary Outcomes: PNM, PTD, LBW, SGA 15 studies met inclusion criteria comprising 12,283 IVF singletons and 1.9 million spontaneous conceptions Study Designs of Included Studies All retrospective All unblinded (obstetricians knew IVF status) Most controlled only for age and parity. A few also adjusted for demographics, smoking and obstetric history. All cohort design (3 traditional, 8 matched, 4 external comparison) Jackson, Obstet Gynecol, 2004 Jackson, Obstet Gynecol, 2004 3

Perinatal Mortality IVF Spontaneous Odds ratio Odds ratio Study n n (95% CI) (95% CI) Cohort Gissler 746 188,381 2.4 Matched cohort Dhont 3048 3048 2.3 Koudstaal 307 307 5.1 Reubinoff 260 260 2.0 Verlaenen 140 140 1.5 Westergaard 1298 1298 2.8 External comparison Howe 54 54 1.0 Tanbo 355 643 1.4 Tottal l 102//5199 ((19..6/1000)) Absolute risk 1271/ /192,,993 ((6..6//1000)) 0.01 0.1 1 10 100 2..2 ((1..6--3..0)) Jackson, Obstet Gynecol, 2004 Preterm Delivery (<37 wks) IVF Spontaneous Odds ratio Odds ratio Study n n (95% CI) (95% CI) Cohort Bergh 3298 5.4% 1.7 Gissler 746 188,381 2.2 Von During 477 233,905 2.2 Matched cohort Dhont 3048 3048 2.2 Koivurova 153 287 1.5 Koudstaal 307 307 2.8 Reubinoff 260 260 2.4 Verlaenen 140 140 8.9 Wang 1019 1019 2.3 Westergaard 1298 1298 1.4 External comparison Howe 54 54 0.6 Tan 494 978 1.9 Tanbo 355 643 1.7 Wang 465 9% 1.8 Tottal l 1399/ /12,114 % 11..5% 221,,947/410,690 2..0 ((1..7 -- 2..2)) 5..3% 0.1 1 10 100 Favors IVF Favors spontaneous Jackson, Obstet Gynecol, 2004 Low Birth Weight (<2500g) IVF Spontaneous Odds ratio Odds ratio Study n n (95% CI) (95% CI) Cohort Bergh 3295 3.6% 1.2 Gissler 746 188,381 2.4 Matched cohort Dhont 3048 3048 2.1 Koivurova 153 287 1.9 Koudstaal 307 307 2.2 Reubinoff 260 260 1.0 Verlaenen 140 140 2.5 Westergaard 1298 1298 1.5 External comparison Tan 494 978 2.2 Tanbo 355 643 1.8 VLBW (<1500g) IVF Spontaneous Odds ratio Odds ratio Study n n (95% CI) (95% CI) Cohort Bergh 3295 0.6% 2.6 Gissler 746 188,381 3.6 Von During 542 233,585 2.4 Matched cohort Dhont 3048 3048 3.7 Koivurova 153 287 3.0 Verlaenen 140 140 1.7 Westergaard 1298 1298 3.8 External comparison Tanbo 355 643 1.7 Total % 957/10,096 (9.5%) 7371/195,342 (3.8%) 1.8 (1.4-2.2) Total 240/9577 (2.5%) 4213/427,382 (0.99%) 2.7 (2.3-3.1) 0.1 1 10 0.1 1 10 100 4

SGA (<10%) Additional outcomes: caution! IVF Spontaneous Odds ratio Odds ratio Study n n (95% CI) (95% CI) Matched cohort Koudstaal 307 307 2.3 Maman 169 469 1.0 Reubinoff 260 260 1.0 Verlaenen 140 140 2.3 External comparison Howe 54 54 0.3 Tan 494 978 2.0 Wang 465 10% 1.6 Fewer studies Outcomes not as clearly defined or vary from study to study Total % 275/1889 (14.6%) 198/2208 (8.9%) 1.6 (1.3-2.0) 0.1 1 10 More antenatal outcomes More L&D outcomes Number IVF Spont Odds Ratio Odds Ratio Outcome Studies % % (95% CI) (95% CI) Antepartum Delivery <32-33 weeks 4 3.0 0.7 3.1 (2.0-4.8) Gestational diabetes 4 6.8 4.7 2.0 (1.4-3.0) Malpresentation 7 6.5 5.4 1.0 (0.7-1.4) Placenta previa 6 2.4 0.9 2.9 (1.5-5.4) Preeclampsia 8 10.3 3.8 1.6 (1.2-2.0) Preterm delivery after spontaneous labor 5 10.3 5.6 2.1 (1.7-2.7) Stillbirth 7 1.2 0.9 2.6 (1.8-3.6) Vaginal bleeding 7 16.6 2.9 2.5 (1.9-3.3) Labor and delivery 0.1 1 10 Number IVF Spont Odds Ratio Odds Ratio Outcome Studies % % (95% CI) (95% CI) Labor induction 7 21.9 19.6 1.2 (1.0-1.3) Spontaneous labor 7 49.0 61.3 0.57 (0.5-0.7) Operative vaginal delivery 6 12.0 7.3 0.67 (0.6-0.8) Cesarean delivery 13 26.7 19.4 2.1 (1.7-2.6) Elective Cesarean 7 11.4 6.7 1.9 (1.5-2.5) Emergent Cesarean 7 8.0 5.9 1.5 (1.1-2.0) 0.1 1 10 5

More neonatal outcomes Is the risk real? Number IVF Spont Odds Ratio Odds Ratio Outcome Studies % % (95% CI) (95% CI) NICU admission 5 17.8 7.8 1.6 (1.3-2.0) Neonatal death 7 0.6 0.3 2.0 (1.2-3.4) 0.1 1 10 Same results despite differing populations & study designs Most odds ratios are >2 Higher quality studies found higher OR s Or is it bias? Hard Outcomes These are not RCT s and so are fraught with bias (information bias, treatment bias, selection bias, recall bias etc) Treatment bias AKA precious pregnancy : Higher rates of prenatal visits & procedures, antepartum hospitalization, elective C/S, and induction in IVF group. Are these indicated or due to patient and MD worry? These interventions could lead to iatrogenic increases in PTD and LBW. Could treatment bias explain our results? IVF Spontaneous Odds ratio Odds ratio Outcome % % (95% CI) (95% CI) PNM 2.0 0.66 2.2 (1.6-3.0) SGA 14.6 8.9 1.6 (1.3-2.0) VLBW 2.5 0.99 2.7 (2.3-3.1) VPTD (<32 wks) 3.0 0.70 3.1 (2.0-4.8) Placenta Previa 2.4 0.88 2.9 (1.5-5.4) 0.10 1.00 10.00 6

Additional risks: Malformations, CP, development and imprinting disorders Major malformations Meta-analysis of Major Malformations (MM) CAUTION! Data from individual studies (not metaanalyses) These outcomes are difficult to define and their definition varies from study to study These outcomes could be higher in the IVF group because they are looking harder for them (ascertainment bias) OR 1.29 (1.01-1.67) (IVF/ ICSI) Limited by: Heterogeneous definitions of MM Heterogeneous study design Some studies controlled for maternal age, plurality, and other important factors, others did not Rimm, J Asst Repro Gen, 2004 Cerebral Palsy Two large population based cohort studies Significantly increased risk of CP in IVF group (RR of 1.6 to 2.8) before adjusted for PTD 1. Stromberg showed continued increased risk after adjustment for PTD whereas 2. Hyidtjorn showed no increased risk of IVF after adjustment for PTD Nonetheless, overall rate of CP is higher in IVF because of higher rate of PTD Stromberg, Lancet, 2002: Hvidtjorn, Pediatrics, 2006 Developmental Delay (DD) Difficult to define, many different measures Most studies very small: n=50-200. Most show no difference but a few showed lower mental development scores and/or more developmental delay in ICSI children compared with spontaneous conceptions Largest study (5680 IVF), Stromberg, showed increased DD with RR of 2.8 for singles + twins even after adjust for PTD and other factors. Non-significant increase (RR-2.6) in singletons alone. Stromberg, Lancet, 2002 7

Imprinting Disorders Imprinting 2 paternal sets of chromosomes: Hydatiforme Mole 2 maternal copies sets of chromosomes: Teratoma Beckwith-Widemann Syndrome Macroglossia Visceromegaly Macrosomia Omphalocele Microcephaly Embryonal Tumors Angelman Syndrome Developmental delay Speech impairment Ataxia Happy demeanor Microcephaly Seizures. 3. Why ART pregnancies might have worse outcomes? 1. The Patient 2. The Procedure(s) 3. The Obstetrician 8

Patient Related Risk Factors Low Birth Weight Age Nulliparity Prior poor pregnancy outcomes? Infertility 56 yo British woman with twins Infertile patients with spontaneous conception Modified from Olivennes et al., 2002 Author Odds Ratio Year Wilson 1.4 1963 Funderbunk 1.9 1975 Berkowitz 1.9 1981 Olsen 1.4 1983 Varma 1.7 1987 Tuck 2.4 1988 Ghazi 1.8 1991 Bhalla 1.4 1992 Very Low birth Weight The Procedure 3 2.5 ODDs Ratio 2 1.5 1 0.5 0 Control Subfertile no RX Subfertile and Rx McElrath et al, 1997 9

Methylation and Expression Methylation changes during preimplantation development 1. DNA methylation 2. genomic imprinting 3. histone modification Could it be placentation? Controlled studies show more abnormal morphologies in IVF singleton placentae Higher incidence of placenta previa and abruption Higher incidence of preeclampsia and growth restriction: both of which may be related to abnormal placental function Role of Obstetric Management The worry factor or precious pregnancy bias causes increased interventions More prenatal visits and procedures More antepartum hospitalizations More labor inductions and cesarean sections 10

Twins Meta-analysis Things in perspective: the twins data PNM: 1.4 (0.2-9.1) PTD: 1.6 (1.01-2.4) LBW: 1.1 (0.9-1.5) SGA: 0.9 (0.6-1.4) Maternal hospitalization 4.7 (1.2-8.2) Cesarean: 1.3 (1.1-1.7) NICU: 2.2 (1.6-3.0) McDonald, AJOG, 2005 Increased risk in singletons but not twins? Could be a sample size problem (confidence intervals wider for twins meta than for singles meta) The added risk of IVF/infertility has a marked impact on a low risk singleton pregnancy but this added risk is not detectable in the already high risk twin pregnancies Role of Obstetric Management ACOG Committee Opinion: 2005 Advise counseling about 1. obstetric risks especially for twins but also for singletons, 2. possible chromosomal abnormalities following ICSI in severe male factor cases, 3. and genomic imprinting modifications. Note that absolute risk to IVF babies is small The single most important health effect of ART for the offspring remains iatrogenic multiple fetal pregnancy supports efforts to decrease multiples 11

Summary 1. 3 meta-analyses analyses revealed worse perinatal outcomes for IVF singletons, independent of age and parity. 2. The etiology for these adverse outcomes is unknown but may be related to abnormal placentation and/or infertility 3. IVF twins seem to be at slightly higher or no higher risk than spontaneous twins Conclusions New technological solutions offer unprecedented hope to infertile couple, with excellent success. The risks of the procedures are not yet clearly defined/ understood and deserve further evaluation. 4. The quality of the evidence is Level II-2 ( well-designed case-control control or cohort studies ) Does IVF cause adverse perinatal outcomes? Paolo Rinaudo *, MD PhD Rebecca A. Jackson %, MD rinaudop@obgyn.ucsf.edu Departments of Ob/Gyn & *Center for Reproductive Sciences & % Epi/Biostats University of California, San Francisco 12